Literature DB >> 10744646

Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia.

P Hubert1, F Bergeron, V Ferreira, M Seligmann, E Oksenhendler, P Debre, B Autran.   

Abstract

Idiopathic CD4(+) lymphocytopenia (ICL) is defined by a stable loss of CD4(+) T cells in the absence of any known cause of immune deficiency. This syndrome is still of undetermined origin. It affects adult patients, some of them displaying opportunistic infections similar to HIV-infected subjects. The hypothesis that the cellular immune defect may be due to biochemical failures of the CD3-TCR pathway is investigated here in a patient associating a severe selective CD4(+) lymphocytopenia with an increased CD8(+) T cell count discovered in the course of a cryptococcal meningitidis. A 40% reduction of T cell proliferation to CD3-TCR stimulation is observed only in the CD4(+) subpopulation. The early CD3-induced protein tyrosine phosphorylations are conserved in both CD4(+) and CD8(+) subsets, and the levels of the T cell protein tyrosine kinases p56(Lck), p59(Fyn) and ZAP-70 are normal. However, we find a 50% reduction of p56(Lck) kinase activity in the patient's T cells compared to a healthy control donor. p59(Fyn) activity does not appear to be altered. Nevertheless, we do not find any genetic abnormality of p56(Lck). These results thus suggest that a defect of an unknown protein regulating p56(Lck) activity takes place in this patient's T cells. Taken together, these findings reveal p56(Lck) alteration in ICL and confirm the critical role of this kinase in the maintenance of the peripheral CD4(+) T cell subpopulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744646     DOI: 10.1093/intimm/12.4.449

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  18 in total

Review 1.  Consequences of a mutation in the UNC119 gene for T cell function in idiopathic CD4 lymphopenia.

Authors:  Magdalena M Gorska; Rafeul Alam
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

2.  On the activation and deactivation pathways of the Lck kinase domain: a computational study.

Authors:  Josephine Alba; Edoardo Milanetti; Marco D'Abramo
Journal:  J Comput Aided Mol Des       Date:  2019-05-10       Impact factor: 3.686

3.  Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia.

Authors:  Ainhoa Perez-Diez; Chun-Shu Wong; Xiangdong Liu; Harry Mystakelis; Jian Song; Yong Lu; Virginia Sheikh; Jeffrey S Bourgeois; Andrea Lisco; Elizabeth Laidlaw; Cornelia Cudrici; Chengsong Zhu; Quan-Zhen Li; Alexandra F Freeman; Peter R Williamson; Megan Anderson; Gregg Roby; John S Tsang; Richard Siegel; Irini Sereti
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

4.  A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia.

Authors:  Magdalena M Gorska; Rafeul Alam
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

5.  Downregulation of p56(lck) tyrosine kinase activity in T cells of squirrel monkeys (Saimiri sciureus) correlates with the nontransforming and apathogenic properties of herpesvirus saimiri in its natural host.

Authors:  T Greve; G Tamgüney; B Fleischer; H Fickenscher; B M Bröker
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 6.  Genetics of SCID.

Authors:  Fausto Cossu
Journal:  Ital J Pediatr       Date:  2010-11-15       Impact factor: 2.638

Review 7.  Partial defects of T-cell development associated with poor T-cell function.

Authors:  Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-03-05       Impact factor: 10.793

Review 8.  Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells.

Authors:  Dimitrios Zonios; Virginia Sheikh; Irini Sereti
Journal:  Arthritis Res Ther       Date:  2012-08-31       Impact factor: 5.156

9.  Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia.

Authors:  Florence Bugault; Daniela Benati; Luc Mouthon; Ivan Landires; Pierre Rohrlich; Vincent Pestre; Jacques Thèze; Olivier Lortholary; Lisa A Chakrabarti
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

Review 10.  New genetic discoveries and primary immune deficiencies.

Authors:  Vivian Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.